{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:37:59Z","timestamp":1791308279627,"version":"4.3.1"},"reference-count":272,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation pour la Recherche sur le Cerveau"},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["Equipe FRM DEQ2014039529"],"award-info":[{"award-number":["Equipe FRM DEQ2014039529"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Ministry of Research","award":["ANR-12-BSV1-0015-01"],"award-info":[{"award-number":["ANR-12-BSV1-0015-01"]}]},{"name":"French Ministry of Research","award":["ANR-11-IDEX-0004-02"],"award-info":[{"award-number":["ANR-11-IDEX-0004-02"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pharmthera.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T21:30:30Z","timestamp":1476912630000},"page":"14-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["New therapeutic opportunities for 5-HT2 receptor ligands"],"prefix":"10.1016","volume":"170","author":[{"given":"Luc","family":"Maroteaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Ayme-Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Aubertin-Kirch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Banas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Quentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Monassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.10.008_bb0005","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1523\/JNEUROSCI.3905-08.2009","article-title":"Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function","volume":"29","author":"Abdallah","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0010","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/1471-2164-13-572","article-title":"An integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiation","volume":"13","author":"Aij\u00f6","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neuropharm.2011.05.023","article-title":"Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors","volume":"61","author":"Albizu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0020","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.1103964108","article-title":"Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient mice","volume":"108","author":"Amireault","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/acschemneuro.5b00094","article-title":"Serotonin (5-HT) 5-HT2A receptor (5-HT2AR):5-HT2CR imbalance in medial prefrontal cortex associates with motor impulsivity","volume":"6","author":"Anastasio","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0030","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S1474-4422(07)70218-1","article-title":"Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease","volume":"6","author":"Antonini","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/humrep\/deh698","article-title":"Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: New evidence and a systematic review","volume":"20","author":"Arslan","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1593\/neo.81630","article-title":"Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1\/2 phosphorylation","volume":"11","author":"Asada","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0045","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1128\/JVI.02252-13","article-title":"5-HT2 receptors facilitate JC polyomavirus entry","volume":"87","author":"Assetta","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0050","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1471-4159.2010.06848.x","article-title":"The central serotonin 2B receptor: A new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity","volume":"114","author":"Auclair","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0055","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1021\/jm960062t","article-title":"Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5-HT2B) contractile receptor in the rat stomach fundus","volume":"39","author":"Audia","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1472-8206.2012.01027.x","article-title":"Mitral bioprosthesis hypertrophic scaring and native aortic valve fibrosis during benfluorex therapy","volume":"26","author":"Ayme-Dietrich","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0065","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1097\/HJH.0000000000000695","article-title":"Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats","volume":"33","author":"Ayme-Dietrich","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0070","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/j.1440-1681.2010.05388.x","article-title":"Role of 5-HT2B receptor in cardiomyocyte apoptosis of norepinephrine-induced cardiomyopathy model in rats","volume":"37","author":"Bai","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/npp.2010.173","article-title":"Deconstructing antiobesity compound action: Requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects","volume":"36","author":"Banas","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0080","doi-asserted-by":"crossref","first-page":"E1382","DOI":"10.1073\/pnas.1525586113","article-title":"Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning","volume":"113","author":"Barre","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0085","doi-asserted-by":"crossref","first-page":"26066","DOI":"10.1074\/jbc.M109.073791","article-title":"The serotonergic 5-HT2B receptor controls tissue non-specific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C","volume":"285","author":"Baudry","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0090","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1074\/jbc.M008089200","article-title":"Interaction of serotonin 5-HT2C receptors with PDZ10 of the multi PDZ protein MUPP1","volume":"276","author":"Becamel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/mol.113.089086","article-title":"Role of the N-terminal region in G-protein coupled receptor functions: Negative modulation revealed by 5-HT2B receptor polymorphisms","volume":"85","author":"Belmer","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.peptides.2015.07.008","article-title":"Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes","volume":"71","author":"Bennet","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0110","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1172\/JCI70338","article-title":"Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis","volume":"123","author":"Berglund","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0115","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09629","article-title":"A population-specific HTR2B stop codon predisposes to severe impulsivity","volume":"468","author":"Bevilacqua","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0120","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1074\/jbc.M006968200","article-title":"The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis","volume":"276","author":"Bhatnagar","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajmg.a.31606","article-title":"Whole genome microarray analysis of gene expression in Prader\u2013Willi syndrome","volume":"143","author":"Bittel","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.schres.2009.12.005","article-title":"Do atypical antipsychotic drugs reduce the risk of ischemic heart disease and mortality? Possible role of 5-HT2A receptor blockade","volume":"119","author":"Blasco-Fontecilla","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S8756-3282(01)00593-2","article-title":"Neurotransmitter action in osteoblasts: Expression of a functional system for serotonin receptor activation and reuptake","volume":"29","author":"Bliziotes","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0140","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.1995.tb14977.x","article-title":"The pharmacology and distribution of human 5-hydroxytryptamine 2B (5-HT2B) receptor gene products: Comparison with 5-HT2A and 5-HT2C receptors","volume":"115","author":"Bonhaus","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0145","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0702632","article-title":"RS-127445: A selective, high affinity, orally bioavailable 5-HT2B receptor antagonist","volume":"127","author":"Bonhaus","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0028-3908(97)00049-X","article-title":"RS-102221: A novel high affinity and selective, 5-HT2C receptor antagonist","volume":"36","author":"Bonhaus","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.04.035","article-title":"(1R, 3S)-(\u2212)-trans-PAT: A novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist\/antagonist activity","volume":"615","author":"Booth","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0091-3057(95)00207-3","article-title":"Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine","volume":"53","author":"Bourson","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1746-6148-9-251","article-title":"The expression and role of serotonin receptor 5HTR2A in canine osteoblasts and an osteosarcoma cell line","volume":"9","author":"Bracha","year":"2013","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0170","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0026-895X(25)09519-7","article-title":"[3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor","volume":"38","author":"Branchek","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00395-007-0648-1","article-title":"Expression of mRNA encoding G protein-coupled receptors involved in congestive heart failure\u2014A quantitative RT-PCR study and the question of normalisation","volume":"102","author":"Brattelid","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0180","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1124\/mol.108.054395","article-title":"Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimers","volume":"75","author":"Brea","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","article-title":"Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: A comprehensive history, a re-evaluation of mechanisms, and its utility as a model","volume":"4","author":"Canal","year":"2012","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0190","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.113.212373","article-title":"A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist\/5-HT2B inverse agonist with preclinical efficacy for psychoses","volume":"349","author":"Canal","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-010-1784-0","article-title":"The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen","volume":"209","author":"Canal","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0200","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ajpath.2015.11.018","article-title":"Serotonin is involved in autoimmune arthritis through Th17 immunity and bone resorption","volume":"186","author":"Chabbi-Achengli","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075783","article-title":"Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-\u00df\/\u03b4 in osteoblasts","volume":"8","author":"Chabbi-Achengli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2007.09.006","article-title":"Pathogenic mechanisms of pulmonary arterial hypertension","volume":"44","author":"Chan","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0215","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/mol.107.041574","article-title":"Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: Differential modulation of cell surface expression and signal transduction","volume":"73","author":"Chanrion","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0220","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4103\/0366-6999.158285","article-title":"Prospective randomized study of sarpogrelate versus clopidogrel-based dual antiplatelet therapies in patients undergoing femoropopliteal arterial endovascular interventions: Preliminary results","volume":"128","author":"Chen","year":"2015","journal-title":"Chin Med J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0225","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0269881113510071","article-title":"Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons","volume":"28","author":"Chenu","year":"2014","journal-title":"J Psychopharmacol (Oxf)"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0230","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0014-5793(94)00968-6","article-title":"The human serotonin 5-HT2B receptor: Pharmacological link between 5-HT2 and 5-HT1D receptors","volume":"352","author":"Choi","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pr.54.2.323","article-title":"G protein-coupled receptor allosterism and complexing","volume":"54","author":"Christopoulos","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0240","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002130000504","article-title":"Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat","volume":"152","author":"Clifton","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0245","first-page":"131","article-title":"LY272015, a potent, selective and orally active 5-HT2B receptor antagonist","volume":"3","author":"Cohen","year":"1996","journal-title":"J Ser Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0250","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1096\/fj.07-9209com","article-title":"The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation","volume":"22","author":"Collet","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0255","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.npp.1300662","article-title":"3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221","volume":"30","author":"Conductier","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0260","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajmg.b.30972","article-title":"Association study of the serotoninergic system in migraine in the Spanish population","volume":"153B","author":"Corominas","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm.3766","article-title":"Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis","volume":"21","author":"Crane","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rvsc.2015.03.020","article-title":"Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease","volume":"100","author":"Cremer","year":"2015","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0280","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tvjl.2014.12.016","article-title":"Serotonin markers show altered transcription levels in an experimental pig model of mitral regurgitation","volume":"203","author":"Cremer","year":"2015","journal-title":"Vet J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0285","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/cn300072u","article-title":"Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction","volume":"4","author":"Cunningham","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2008.07.040","article-title":"Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq\/11 activation and calcium mobilisation in CHO cells","volume":"594","author":"Cussac","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0295","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00210-001-0505-y","article-title":"Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: Influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols","volume":"365","author":"Cussac","year":"2002","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0300","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.4049\/jimmunol.1201133","article-title":"Serotonin skews human macrophage polarization through HTR2B and HTR7","volume":"190","author":"de Las Casas-Engel","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0305","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0149-7634(99)00083-4","article-title":"Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: Possible mechanisms of action","volume":"24","author":"De Vry","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0310","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20101629","article-title":"Platelet derived serotonin links vascular disease and tissue fibrosis","volume":"208","author":"Dees","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0315","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/brain\/aws274","article-title":"Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: A link to spasticity","volume":"136","author":"Dentel","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0320","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2006.03.043","article-title":"The contractile effect of the ghrelin receptor antagonist, D-Lys3-GHRP-6, in rat fundic strips is mediated through 5-HT receptors","volume":"537","author":"Depoortere","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuropharm.2015.06.012","article-title":"Central serotonin2B receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow","volume":"97","author":"Devroye","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/mp.2011.159","article-title":"5-HT2B receptors are required for serotonin-selective antidepressant actions","volume":"17","author":"Diaz","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0335","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00223-013-9810-y","article-title":"Deletion of serotonin 2B receptor provokes structural alterations of mouse dental tissues","volume":"94","author":"Dimitrova-Nakov","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0340","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/cn300020x","article-title":"Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators","volume":"3","author":"Ding","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0345","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.eururo.2005.02.006","article-title":"Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines","volume":"47","author":"Dizeyi","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0350","doi-asserted-by":"crossref","first-page":"e7952","DOI":"10.1371\/journal.pone.0007952","article-title":"Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice","volume":"4","author":"Doly","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0355","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.5723-07.2008","article-title":"Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro","volume":"28","author":"Doly","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0360","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/09031936.00126010","article-title":"Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"37","author":"Dumitrascu","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0365","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/nm.2490","article-title":"Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease","volume":"17","author":"Ebrahimkhani","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0370","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-016-1534-4","article-title":"Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis","author":"El Oussini","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0375","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"Elphick","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0380","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1183\/09031936.00126907","article-title":"Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice","volume":"32","author":"Fabre","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0385","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.110.172247","article-title":"Interaction of 5-HT2A and 5-HT2C receptors in R(\u2212)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice","volume":"335","author":"Fantegrossi","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0390","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archsurg.143.9.841","article-title":"Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling","volume":"143","author":"Fernandez-Ranvier","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0400","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/j.1460-2075.1992.tb05427.x","article-title":"Cloning and functional characterization of the rat stomach fundus serotonin receptor","volume":"11","author":"Foguet","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0405","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00001756-199204000-00014","article-title":"Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes","volume":"3","author":"Foguet","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0410","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0415","first-page":"1219","article-title":"Selective blockade of serotonin 5-HT2A receptor increases coronary blood flow via augmented cardiac nitric oxide release through 5-HT1B receptor in hypoperfused canine hearts","volume":"37","author":"Fujita","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"7 Suppl","key":"10.1016\/j.pharmthera.2016.10.008_bb0420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0195-6663(86)80050-2","article-title":"Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system","author":"Garattini","year":"1986","journal-title":"Appetite"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2014.02.043","article-title":"The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats","volume":"731","author":"Garcia-Pedraza","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0430","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1113\/jphysiol.2008.164152","article-title":"Pharmacological targeting of the serotonergic system for the treatment of obesity","volume":"587","author":"Garfield","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0435","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1091\/mbc.e06-03-0218","article-title":"Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability","volume":"17","author":"Gavarini","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0440","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0445","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF02244895","article-title":"Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers","volume":"112","author":"Goodall","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0450","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-016-3951-2","article-title":"Serotonin competence of mouse beta cells during pregnancy","author":"Goyvaerts","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0460","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0465","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0021-9150(03)00054-6","article-title":"Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism","volume":"168","author":"Hayashi","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0470","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","article-title":"Serotonin reciprocally regulates melanocortin neurons to modulate food intake","volume":"51","author":"Heisler","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0475","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1523\/JNEUROSCI.2584-06.2007","article-title":"Serotonin activates the hypothalamic\u2013pituitary\u2013adrenal axis via serotonin 2C receptor stimulation","volume":"27","author":"Heisler","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0480","first-page":"235","article-title":"Aortic and mitral valve disease induced by ergotamine therapy for migraine: A case report and review of the literature","volume":"5","author":"Hendrikx","year":"1996","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0485","doi-asserted-by":"crossref","first-page":"40144","DOI":"10.1074\/jbc.M507396200","article-title":"Inhibition of serotonin 5-hydroxytryptamine2C receptor function through heterodimerization: Receptor dimers bind two molecules of ligand and one G-protein","volume":"280","author":"Herrick-Davis","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0490","doi-asserted-by":"crossref","first-page":"13963","DOI":"10.1021\/bi048398p","article-title":"Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells","volume":"43","author":"Herrick-Davis","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0495","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2010.04.078","article-title":"Functional expression of 5-HT2A receptor in osteoblastic MC3T3-E1 cells","volume":"396","author":"Hirai","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0500","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1254\/jphs.08243SC","article-title":"Expression of mRNA for 5-HT2 receptors and proteins related to inactivation of 5-HT in mouse osteoblasts","volume":"109","author":"Hirai","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0505","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2004.01.009","article-title":"Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells","volume":"1002","author":"Hisaoka","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0510","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biopsych.2012.11.003","article-title":"Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function","volume":"74","author":"Hodge","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0515","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0520","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1248\/bpb.b12-00401","article-title":"Mechanism of inverse agonist action of sarpogrelate at the constitutively active mutant of human 5-HT2A receptor revealed by molecular modeling","volume":"35","author":"Hossain","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0525","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.4049\/jimmunol.172.10.6011","article-title":"The serotoninergic receptors of human dendritic cells: Identification and coupling to cytokine release","volume":"172","author":"Idzko","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0530","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/07435800902889685","article-title":"Beneficial effects of sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, supplemented with pioglitazone on diabetic model mice","volume":"34","author":"Iizuka","year":"2009","journal-title":"Endocr Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0535","first-page":"565","article-title":"Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray","volume":"24","author":"Iizuka","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0540","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2011.10.042","article-title":"Role of serotonin in angiogenesis: Induction of angiogenesis by sarpogrelate via endothelial 5-HT1B\/Akt\/eNOS pathway in diabetic mice","volume":"220","author":"Iwabayashi","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0545","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.108.180976","article-title":"Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy","volume":"104","author":"Jaffre","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0550","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.0000139856.20505.57","article-title":"Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: Control of interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts","volume":"110","author":"Jaffr\u00e9","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0555","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1124\/mol.106.032656","article-title":"Modified receptor internalization upon co-expression of 5-HT1B receptor and 5-HT2B receptors","volume":"71","author":"Janoshazi","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0560","doi-asserted-by":"crossref","first-page":"16335","DOI":"10.1073\/pnas.0701471104","article-title":"Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens","volume":"104","author":"Jean","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0565","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)00775-0","article-title":"Pharmacological characterisation of human 5-HT2 receptor subtypes","volume":"414","author":"Jerman","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0570","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1349","article-title":"Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse","volume":"12","author":"Ji","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0575","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1468-2982.2003.00464.x","article-title":"Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation","volume":"23","author":"Johnson","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0580","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.3399891","article-title":"Molecular characterization of a functional cDNA encoding the serotonin 1c receptor","volume":"241","author":"Julius","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0585","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1074\/jbc.M114.559542","article-title":"Convergence of melatonin and serotonin (5-HT) signaling at MT2\/5-HT2C receptor heteromers","volume":"290","author":"Kamal","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0590","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/path.4122","article-title":"Influence of age on wound healing and fibrosis","volume":"229","author":"Kapetanaki","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0595","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2176\/nmc.53.291","article-title":"Sarpogrelate dilates cerebral arteries in the absence of exogenous serotonin","volume":"53","author":"Kawamura","year":"2013","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0605","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0028-3908(96)00171-2","article-title":"BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0610","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1996.tb15208.x","article-title":"In vitro and in vivo profile of SB 206553, a potent 5-HT2C\/5-HT2B receptor antagonist with anxiolytic-like properties","volume":"117","author":"Kennett","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0615","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WNF.0b013e318184fafd","article-title":"The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive\u2013compulsive symptoms in schizophrenia","volume":"32","author":"Kim","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0620","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.2173","article-title":"Serotonin regulates pancreatic beta cell mass during pregnancy","volume":"16","author":"Kim","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0625","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1118265","article-title":"The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C","volume":"311","author":"Kishore","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0630","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.109.160432","article-title":"Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)\/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: In vitro and neurochemical profile","volume":"333","author":"Kiss","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0635","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10456-009-9145-5","article-title":"Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1","volume":"12","author":"Klein","year":"2009","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0640","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","article-title":"Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors","volume":"370","author":"Knight","year":"2004","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0645","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jvs.2008.11.071","article-title":"Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft","volume":"49","author":"Kodama","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0650","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1253\/circj.70.1451","article-title":"Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease","volume":"70","author":"Kokubu","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0655","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/cn5003489","article-title":"Serotonin modulates developmental microglia via 5-HT2B receptors: Potential implication during synaptic refinement of retinogeniculate projections","volume":"6","author":"Kolodziejczak","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0660","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/thx.2009.134353","article-title":"Increased expression of 5-hydroxytryptamine2A\/B receptors in idiopathic pulmonary fibrosis: A rationale for therapeutic intervention","volume":"65","author":"K\u00f6nigshoff","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0665","first-page":"363","article-title":"Expression and localization of serotonin receptors in human breast cancer","volume":"33","author":"Kopparapu","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0670","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0026-895X(25)09676-2","article-title":"Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor","volume":"46","author":"Kursar","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0675","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0026-895X(25)08969-2","article-title":"Molecular cloning, functional expression, and pharmacological characterisation of a novel serotonin (5-Hydroxytryptamine2F) from rat stomach fundus","volume":"42","author":"Kursar","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0680","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1091\/mbc.e08-04-0422","article-title":"Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling","volume":"19","author":"Labasque","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0685","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00702-013-1011-3","article-title":"Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice","volume":"120","author":"Lairez","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0690","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/en.2007-1321","article-title":"Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors","volume":"149","author":"Lam","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0695","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1210\/jc.2006-0221","article-title":"Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome","volume":"91","author":"Lampron","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0700","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/mp.2013.97","article-title":"Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons","volume":"19","author":"Lanteri","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0705","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1074\/jbc.271.6.3141","article-title":"Ras involvement in signal transduction by the serotonin 5-HT2B receptor","volume":"271","author":"Launay","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0710","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood-2011-06-358374","article-title":"Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension","volume":"119","author":"Launay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0715","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension","volume":"8","author":"Launay","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0720","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1096\/fj.06-5724com","article-title":"Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells","volume":"20","author":"Launay","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0725","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/intimm\/dxh112","article-title":"Gene expression profiles during human CD4+ T cell differentiation","volume":"16","author":"Lee","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0730","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0006-3223(98)00186-3","article-title":"Hypothalamic serotonin in control of eating behavior, meal size, and body weight","volume":"44","author":"Leibowitz","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0735","first-page":"96","article-title":"Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells","volume":"5","author":"Li","year":"2006","journal-title":"HBPD INT"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0740","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-4598-12-14","article-title":"Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a","volume":"12","author":"Liang","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0745","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardiores.2006.08.003","article-title":"Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes","volume":"72","author":"Liang","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0750","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1165\/rcmb.2005-0163OC","article-title":"Serotonin-induced growth of pulmonary artery smooth muscle requires activation of PI3K\/Akt\/S6K1","volume":"34","author":"Liu","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0755","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1126\/science.1244142","article-title":"Serial femtosecond crystallography of G protein-coupled receptors","volume":"342","author":"Liu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0760","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cellsig.2005.06.006","article-title":"Stepwise control of osteogenic differentiation by 5-HT2B receptor signaling: Nitric oxide production and phospholipase A2 activation","volume":"18","author":"Locker","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0765","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-5793(92)80936-B","article-title":"New mouse 5-HT2-like receptor: Expression in brain, heart, and intestine","volume":"312","author":"Loric","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0770","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2010.12.044","article-title":"5-Hydroxytryptamine induces cyclooxygenase-2 in rat vascular smooth muscle cells: Mechanisms involving Src, PKC and MAPK activation [corrected]","volume":"656","author":"Machida","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0775","first-page":"5692","article-title":"Expression profiling reveals hepsin overexpression in prostate cancer","volume":"61","author":"Magee","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0780","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/embor.2008.27","article-title":"Ligand sensitivity in dimeric associations of the serotonin 5HT2C receptor","volume":"9","author":"Mancia","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0785","doi-asserted-by":"crossref","first-page":"9324","DOI":"10.1074\/jbc.275.13.9324","article-title":"PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor","volume":"275","author":"Manivet","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0790","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbadis.2012.09.009","article-title":"Serotonin paracrine signaling in tissue fibrosis","volume":"1832","author":"Mann","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0795","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1074\/jbc.M308742200","article-title":"RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2C receptor isoforms","volume":"279","author":"Marion","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0800","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2014.03.001","article-title":"Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs","volume":"42","author":"Martin","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109312","article-title":"A dynamic view of molecular switch behavior at serotonin receptors: Implications for functional selectivity","volume":"9","author":"Mart\u00ed-Solano","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0810","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HJH.0000000000000159","article-title":"Old spontaneously hypertensive rats gather together typical features of human chronic left-ventricular dysfunction with preserved ejection fraction","volume":"32","author":"Marzak","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0815","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1158\/1078-0432.CCR-05-2003","article-title":"Oncogenic property of acrogranin in human uterine leiomyosarcoma: Direct evidence of genetic contribution in in vivo tumorigenesis","volume":"12","author":"Matsumura","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0820","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","article-title":"Structure and function of serotonin G protein-coupled receptors","volume":"150","author":"McCorvy","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0825","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchemneu.2011.05.001","article-title":"Regulation of dorsal raphe nucleus function by serotonin autoreceptors: A behavioral perspective","volume":"41","author":"McDevitt","year":"2011","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0830","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cmet.2015.04.008","article-title":"Central serotonergic neurons activate and recruit thermogenic brown and beige fat and regulate glucose and lipid homeostasis","volume":"21","author":"McGlashon","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0835","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-328X(96)00058-7","volume":"41","author":"Merzak","year":"1996","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0845","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.yjmcc.2011.07.019","article-title":"Serotonin 5-HT2A receptor-mediated hypertrophy is negatively regulated by caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes","volume":"52","author":"Mialet-Perez","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0850","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0855","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/FJC.0b013e3180325af3","article-title":"Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease","volume":"49","author":"Miyazaki","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0860","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/HYPERTENSIONAHA.107.105551","article-title":"Serotonin 5-HT2B receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice","volume":"52","author":"Monassier","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0865","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainres.2006.02.033","article-title":"Possible involvement of 5alpha-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells","volume":"1085","author":"Morita","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0870","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1254\/jphs.FP0060171","article-title":"Identification of amino acid residues important for sarpogrelate binding to the human 5-hydroxytryptamine2A serotonin receptor","volume":"102","author":"Muntasir","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0875","doi-asserted-by":"crossref","first-page":"13367","DOI":"10.1523\/JNEUROSCI.1437-13.2013","article-title":"Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates","volume":"33","author":"Murnane","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0880","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/jn.00774.2010","article-title":"Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity","volume":"105","author":"Murray","year":"2011","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0885","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0304-3940(87)90425-3","article-title":"Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats","volume":"76","author":"Nabeshima","year":"1987","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0890","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1096\/fj.02-1122fje","article-title":"Serotonin is a novel survival factor of cardiomyocytes: Mitochondria as a target of 5-HT2B-receptor signaling","volume":"17","author":"Nebigil","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0895","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1161\/01.CIR.103.24.2973","article-title":"Ablation of serotonin 5-HT2B receptors in mice leads to abnormal cardiac structure and function","volume":"103","author":"Nebigil","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0900","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.050282397","article-title":"5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross talk with tyrosine kinase pathways","volume":"97","author":"Nebigil","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0905","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00442252","article-title":"Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors","volume":"97","author":"Neill","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00005315","article-title":"Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors","volume":"359","author":"Nelson","year":"1999","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0915","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1158\/0008-5472.CAN-08-0202","article-title":"Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts","volume":"68","author":"Nocito","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0920","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1017\/S1461145706007206","article-title":"Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors","volume":"10","author":"Nonogaki","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0925","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-1192","article-title":"Convergence of the insulin and serotonin programs in the pancreatic \u03b2-cell","volume":"60","author":"Ohta","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0930","first-page":"85","article-title":"A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells","volume":"1","author":"Ohyashiki","year":"2008","journal-title":"Adv Appl Bioinform Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0935","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","article-title":"An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma","volume":"12","author":"Onken","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0940","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1017\/S1461145710001215","article-title":"Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour","volume":"14","author":"Orejarena","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0945","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jvc.2011.12.001","article-title":"Signaling pathways in mitral valve degeneration","volume":"14","author":"Orton","year":"2012","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0950","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.placenta.2010.02.019","article-title":"The 5-HT 2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1\/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines","volume":"31","author":"Oufkir","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0955","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/bcr2448","article-title":"Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival","volume":"11","author":"Pai","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0960","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3748\/wjg.v17.i2.164","article-title":"Switching-on of serotonergic calcium signaling in activated hepatic stellate cells","volume":"17","author":"Park","year":"2011","journal-title":"WJG"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000229","article-title":"Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation","volume":"7","author":"Paulmann","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0970","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.nmd.2012.01.009","article-title":"Role of serotonergic system in the pathogenesis of fibrosis in canine idiopathic inflammatory myopathies","volume":"22","author":"Pavone","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0975","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/npp.2012.111","article-title":"Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats","volume":"37","author":"Pelloux","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0980","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/npp.2012.258","article-title":"Impact of serotonin (5-HT)2C receptors on executive control processes","volume":"38","author":"Pennanen","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0985","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.7221567","article-title":"Two distinct central serotonin receptors with different physiological functions","volume":"212","author":"Peroutka","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0990","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/npp.2015.126","article-title":"Mice lacking the serotonin Htr2B receptor gene present an antipsychotic-sensitive schizophrenic-like phenotype","volume":"40","author":"Pitychoutis","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb0995","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/syn.21592","article-title":"5-HT2A receptor blockade and 5-HT2C receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen","volume":"66","author":"Pockros","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1000","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjp.0702751","article-title":"Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells","volume":"128","author":"Porter","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.109.165001","article-title":"PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats","volume":"334","author":"Porvasnik","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1010","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1002\/j.1460-2075.1988.tb03308.x","volume":"7","author":"Pritchett","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00221-013-3434-3","article-title":"5-HT\u2082a receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: Involvement of the noradrenergic system","volume":"226","author":"Quesseveur","year":"2013","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0024-3205(03)00227-3","article-title":"Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling","volume":"73","author":"Rashid","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.bjp.0702350","article-title":"Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist","volume":"126","author":"Reavill","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5761\/atcs.oa.12.02061","article-title":"Prospective study of sarpogrelate hydrochloride on patients with arteriosclerosis obliterans","volume":"19","author":"Ren","year":"2013","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1035","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1040","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002","article-title":"Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice","volume":"22","author":"Rocha","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainres.2005.12.052","article-title":"Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503","volume":"1073-1074","author":"Rosenzweig-Lipson","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","article-title":"Drugs and valvular heart disease","volume":"356","author":"Roth","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1055","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2006.050767","article-title":"A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis","volume":"169","author":"Ruddell","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1124\/jpet.102.037390","article-title":"5-Hydroxytryptamine2B receptor function is enhanced in the N(omega)-nitro-l-arginine hypertensive rat","volume":"303","author":"Russell","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-007-0810-3","article-title":"Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors","volume":"194","author":"Salomon","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1075","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-291X(91)92105-S","article-title":"Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes","volume":"181","author":"Saltzman","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1566524015666150114113411","article-title":"Serotonin and cancer: What is the link?","volume":"15","author":"Sarrouilhe","year":"2015","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1085","doi-asserted-by":"crossref","DOI":"10.1021\/cn500318q","article-title":"Ghrelin's orexigenic effect is modulated via a serotonin 2C receptor interaction","author":"Schellekens","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(94)80590-3","article-title":"Cloning and functionnal characterisation of the human 5-HT2B serotonin receptor","volume":"342","author":"Schmuck","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1095","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1460-9568.1996.tb01583.x","article-title":"Activation of meningeal 5-HT2B receptors: An early step in the generation of migraine headache?","volume":"8","author":"Schmuck","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1100","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s00125-010-1913-7","article-title":"Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy","volume":"53","author":"Schraenen","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.104.009266","article-title":"Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor","volume":"68","author":"Setola","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1110","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-Methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0269881107082944","article-title":"Asenapine: A novel psychopharmacologic agent with a unique human receptor signature","volume":"23","author":"Shahid","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1120","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1125","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/S0003-4975(01)02599-1","article-title":"Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: Implications for long-term graft patency","volume":"71","author":"Sharma","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuropharm.2006.07.024","article-title":"CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity","volume":"52","author":"Siuciak","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031193","article-title":"Identification of new genes involved in human adipogenesis and fat storage","volume":"7","author":"S\u00f6hle","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1145","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/hep.23441","article-title":"Serotonin promotes tumor growth in human hepatocellular cancer","volume":"51","author":"Soll","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1150","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1158\/1078-0432.CCR-11-1813","article-title":"Expression of serotonin receptors in human hepatocellular cancer","volume":"18","author":"Soll","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1155","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bbrc.2006.03.080","article-title":"The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin","volume":"343","author":"Sonier","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/brbi.1999.0579","article-title":"mRNA expression of serotonin receptors in cells of the immune tissues of the rat","volume":"14","author":"Stefulj","year":"2000","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1165","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2012.09.014","article-title":"Gut-derived serotonin is a multifunctional determinant to fasting adaptation","volume":"16","author":"Sumara","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijcard.2009.09.539","article-title":"Sarpogrelate protects against high glucose-induced endothelial dysfunction and oxidative stress","volume":"147","author":"Sun","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1175","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/cncr.25049","article-title":"The 5-HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment","volume":"116","author":"Svejda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00380-013-0334-1","article-title":"Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia","volume":"29","author":"Takahara","year":"2014","journal-title":"Heart Vessel"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1185","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005344-200402000-00015","article-title":"Effect of sarpogrelate hydrochloride, a 5-HT2 blocker, on insulin resistance in Otsuka Long\u2013Evans Tokushima fatty rats (OLETF rats), a type 2 diabetic rat model","volume":"43","author":"Takishita","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2015.05.048","article-title":"Modulation of osteoblast differentiation and bone mass by 5-HT2A receptor signaling in mice","volume":"762","author":"Tanaka","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1195","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","article-title":"Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: In vitro and in vivo pharmacological characterization","volume":"325","author":"Thomsen","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1200","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1205","first-page":"2578","article-title":"Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities","volume":"63","author":"Tschentscher","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-4159.2008.05357.x","article-title":"Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells","volume":"106","author":"Tsuchioka","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1215","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1167\/iovs.08-2033","article-title":"Gene expression profiling in uveal melanoma: Two regions on 3p related to prognosis","volume":"49","author":"van Gils","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1220","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/FBP.0b013e3283487346","article-title":"Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D\u2082 receptors in mice","volume":"22","author":"Varela","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1225","first-page":"377","article-title":"Serotonin receptor ligands and the treatment of obesity","volume":"5","author":"Vickers","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002130050952","article-title":"Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice","volume":"143","author":"Vickers","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1235","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0028-3908(01)00063-6","article-title":"Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors","volume":"41","author":"Vickers","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002194","article-title":"Cognitive impairment induced by Delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors","volume":"13","author":"Vinals","year":"2015","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1245","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2009.12.001","article-title":"Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors","volume":"391","author":"Vindis","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1250","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.RES.0000207384.81818.d4","article-title":"An in vivo analysis of hematopoietic stem cell potential: Hematopoietic origin of cardiac valve interstitial cells","volume":"98","author":"Visconti","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1255","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1232808","article-title":"Structural features for functional selectivity at serotonin receptors","volume":"340","author":"Wacker","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0026-895X(25)13628-6","article-title":"Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine 2F receptor","volume":"43","author":"Wainscott","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1265","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0022-3565(25)12346-X","article-title":"Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: Evidence for species differences","volume":"276","author":"Wainscott","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1270","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.1232807","article-title":"Structural basis for molecular recognition at serotonin receptors","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147143","article-title":"Serotonin improves high fat diet induced obesity in mice","volume":"11","author":"Watanabe","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1280","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0021-9150(01)00505-6","article-title":"Serotonin potentiates angiotensin II-induced vascular smooth muscle cell proliferation","volume":"159","author":"Watanabe","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1285","first-page":"H944","article-title":"5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats","volume":"276","author":"Watts","year":"1999","journal-title":"Am J Phys"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1290","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(25)12898-X","article-title":"The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats","volume":"277","author":"Watts","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1295","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1183\/09031936.00160407","article-title":"Fenfluramine: Riddle or Rosetta stone?","volume":"31","author":"Weir","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1300","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1305","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1152\/jn.00609.2009","article-title":"Global gene expression analysis of rodent motor neurons following spinal cord injury associates molecular mechanisms with development of postinjury spasticity","volume":"103","author":"Wienecke","year":"2010","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1310","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1074\/jbc.M301905200","article-title":"A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates signal transduction and receptor trafficking","volume":"278","author":"Xia","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1315","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0306-4522(03)00589-X","article-title":"The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro","volume":"122","author":"Xia","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1320","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuron.2008.09.033","article-title":"5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis","volume":"60","author":"Xu","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1325","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.yjmcc.2008.12.019","article-title":"Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors","volume":"46","author":"Yabanoglu","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1330","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","article-title":"A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure","volume":"138","author":"Yadav","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1335","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1254\/jphs.12009FP","article-title":"Serotonin potentiates high-glucose-induced endothelial injury: The role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes","volume":"119","author":"Yamada","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1340","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1634\/stemcells.2007-0048","article-title":"Promoting effects of serotonin on hematopoiesis: Ex vivo expansion of cord blood CD34+ stem\/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis","volume":"25","author":"Yang","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1345","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/stem.1777","article-title":"Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1\/2 and F-actin reorganization","volume":"32","author":"Ye","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1350","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2350-15-29","article-title":"Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma","volume":"15","author":"Zhang","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2011.08.015","article-title":"C-122, a novel antagonist of serotonin receptor 5-HT(2B), prevents monocrotaline-induced pulmonary arterial hypertension in rats","volume":"670","author":"Zopf","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.008_bb1360","first-page":"618","article-title":"mRNA and microRNA expression patterns in adrenocortical cancer","volume":"1","author":"Zsippai","year":"2011","journal-title":"Am J Cancer Res"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:52:53Z","timestamp":1749664373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816301875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":272,"alternative-id":["S0163725816301875"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapeutic opportunities for 5-HT2 receptor ligands","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}